Entre Herman@s Program for HIV Prevention

Recruiting in Palo Alto (17 mi)

Overseen byHomero del Pino, PhD, MS

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Charles Drew University of Medicine and Science

Trial Summary

What is the purpose of this trial?

This trial aims to reduce HIV rates in Latino men who have sex with men by training their siblings to discuss PrEP, a medication that prevents HIV. PrEP is a medication that helps prevent HIV. The study looks at how discussing PrEP compares to discussing other health topics. By promoting PrEP through family support, the trial hopes to increase its use and lower HIV incidence.

Research Team

Homero del Pino, PhD, MS

Principal Investigator

Charles Drew University of Medicine and Science

Eligibility Criteria

This trial is for Latino men under 40 who have sex with men, are HIV-negative, haven't used PrEP recently or at all, and are missing certain vaccines. They must be open to discussing healthcare with a sibling and meet specific criteria like not being in a monogamous relationship with an HIV-negative partner.

Inclusion Criteria

self-identify as Latino

report HIV-negative status

either (a) have never used PrEP or (b) stopped using PrEP at least 90 days ago

See 7 more

Exclusion Criteria

You don't have any of the conditions mentioned above.

are unable to provide consent

Treatment Details

Interventions

Entre Herman@s (Behavioral Intervention)
Vaccines for Health (Behavioral Intervention)

Trial OverviewThe study compares two approaches: one where siblings encourage their gay brothers to use PrEP (a medication to prevent HIV), and another where they talk about getting vaccinated against COVID, Hepatitis A/B, or MPOX instead.

Participant Groups

2Treatment groups

Experimental Treatment

Placebo Group

Group I: PrEP PromotionExperimental Treatment1 Intervention

Group II: Vaccine PromotionPlacebo Group1 Intervention